Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000398424 | SCV000372920 | uncertain significance | Sphingomyelin/cholesterol lipidosis | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000954959 | SCV001101627 | benign | Niemann-Pick disease, type B; Niemann-Pick disease, type A | 2025-01-21 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000252024 | SCV002500210 | benign | not specified | 2022-03-08 | criteria provided, single submitter | clinical testing | Variant summary: SMPD1 c.107_112delTGCTGG (p.Val36_Leu37del) results in an in-frame deletion that is predicted to remove two amino acids from the encoded protein. The variant allele was found at a frequency of 0.0026 in 232506 control chromosomes, predominantly at a frequency of 0.0038 within the South Asian subpopulation in the gnomAD database, including 1 homozygotes. The observed variant frequency within South Asian control individuals in the gnomAD database is approximately 1.7 fold of the estimated maximal expected allele frequency for a pathogenic variant in SMPD1 causing Niemann-Pick Disease phenotype (0.0022), strongly suggesting that the variant is a benign polymorphism found primarily in populations of South Asian origin. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Two classified as benign/likely benign while one classified as VUS. Based on the evidence outlined above, the variant was classified as benign. |
Ce |
RCV001729484 | SCV004135837 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | SMPD1: PM4, BS2 |
Prevention |
RCV003891855 | SCV000305086 | likely benign | SMPD1-related disorder | 2021-03-15 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Diagnostic Laboratory, |
RCV001729484 | SCV001978708 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001729484 | SCV001980388 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Natera, |
RCV001828137 | SCV002091658 | likely benign | Niemann-Pick disease, type A | 2017-08-10 | no assertion criteria provided | clinical testing |